Literature DB >> 25030125

Reasons for low thrombolysis rate in a Norwegian ischemic stroke population.

Kashif Waqar Faiz1, Antje Sundseth, Bente Thommessen, Ole Morten Rønning.   

Abstract

Only a minor proportion of patients with acute ischemic stroke receive treatment with intravenous thrombolysis. The purpose of this study was to explore reasons for not giving thrombolysis and to determine if there was a correlation between prehospital and in-hospital delay in a Norwegian ischemic stroke population. Patients with acute ischemic stroke were included during a 1-year period. Time intervals for prehospital and in-hospital delay, reasons for not treating with thrombolytic therapy in patients admitted within the time window and reasons for late arrival were recorded. In all, 290 patients were included, and 7.6 % were treated with intravenous thrombolysis. The most frequent reasons for not treating eligible patients were: minor symptoms (22.8 %), clinical improvement (17.5 %) and uncertainty about the diagnosis (12.3 %). Patients' reasons for delayed admission were: not attributing their symptoms to stroke (25.4 %), a wait-and-see attitude (25.4 %), and choosing to wait for the GP's office to open (14.3 %). Prehospital delay was strongly correlated to in-hospital delay (p < 0.001). In conclusion, a large percentage of patients with AIS are not treated with thrombolysis because of mild or rapidly improving symptoms, and because patients arrive too late to the hospital. Absolute and relative contraindications account for a minor proportion of reasons for excluding patients.

Entities:  

Mesh:

Year:  2014        PMID: 25030125     DOI: 10.1007/s10072-014-1876-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

1.  Times from symptom onset to hospital arrival in the Get with the Guidelines--Stroke Program 2002 to 2009: temporal trends and implications.

Authors:  David Tong; Mathew J Reeves; Adrian F Hernandez; Xin Zhao; DaiWai M Olson; Gregg C Fonarow; Lee H Schwamm; Eric E Smith
Journal:  Stroke       Date:  2012-04-26       Impact factor: 7.914

2.  The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset.

Authors:  Jeffrey L Saver; Eric E Smith; Gregg C Fonarow; Mathew J Reeves; Xin Zhao; Daiwai M Olson; Lee H Schwamm
Journal:  Stroke       Date:  2010-06-03       Impact factor: 7.914

3.  Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke.

Authors:  Eric E Smith; Abdul R Abdullah; Iva Petkovska; Eric Rosenthal; Walter J Koroshetz; Lee H Schwamm
Journal:  Stroke       Date:  2005-10-06       Impact factor: 7.914

4.  Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms.

Authors:  Joshua Z Willey; Joshua Stillman; Juan A Rivolta; Julio Vieira; Margaret M Doyle; Guillermo Linares; Adrian Marchidann; Mitchell S V Elkind; Bernadette Boden-Albala; Randolph S Marshall
Journal:  Int J Stroke       Date:  2011-11-22       Impact factor: 5.266

5.  Classification and natural history of clinically identifiable subtypes of cerebral infarction.

Authors:  J Bamford; P Sandercock; M Dennis; J Burn; C Warlow
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

Review 6.  Improving public education about stroke.

Authors:  Mark J Alberts
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

7.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

8.  Prehospital delay in acute stroke and TIA.

Authors:  Kashif Waqar Faiz; Antje Sundseth; Bente Thommessen; Ole Morten Rønning
Journal:  Emerg Med J       Date:  2012-08-11       Impact factor: 2.740

9.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  11 in total

Review 1.  Randomized trials of endovascular therapy for stroke--impact on stroke care.

Authors:  Maxim Mokin; Haydy Rojas; Elad I Levy
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

2.  Comparison of the university hospital and county hospitals in western Sweden to identify potential weak links in the early chain of care for acute stroke: results of an observational study.

Authors:  Birgitta Wireklint Sundström; Johan Herlitz; Per Olof Hansson; Peter Brink
Journal:  BMJ Open       Date:  2015-09-08       Impact factor: 2.692

Review 3.  If Time Is Brain Where Is the Improvement in Prehospital Time after Stroke?

Authors:  Jeremy N Pulvers; John D G Watson
Journal:  Front Neurol       Date:  2017-11-20       Impact factor: 4.003

4.  Knowledge of Stroke Risk Factors and Warning Signs in Patients with Recurrent Stroke or Recurrent Transient Ischaemic Attack in Thailand.

Authors:  Jittima Saengsuwan; Pathitta Suangpho; Somsak Tiamkao
Journal:  Neurol Res Int       Date:  2017-10-09

5.  Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics.

Authors:  Marie Dagonnier; Ira Robin Cooke; Pierre Faou; Tara Kate Sidon; Helen Margaret Dewey; Geoffrey Alan Donnan; David William Howells
Journal:  Biomark Insights       Date:  2017-12-20

6.  Hyperacute changes in blood mRNA expression profiles of rats after middle cerebral artery occlusion: Towards a stroke time signature.

Authors:  Marie Dagonnier; William John Wilson; Jenny Margaret Favaloro; Sarah Susan Jane Rewell; Linda Jane Lockett; Stephen Andrew Sastra; Amy Lucienne Jeffreys; Helen Margaret Dewey; Geoffrey Alan Donnan; David William Howells
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

7.  Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers.

Authors:  Yanfeng Zhou; Shijiao Yan; Xingyue Song; Yanhong Gong; Wenzhen Li; Mengdie Wang; Xiaoxv Yin; Bo Hu; Zuxun Lu
Journal:  BMC Neurol       Date:  2019-08-22       Impact factor: 2.474

Review 8.  Acute Stroke Biomarkers: Are We There Yet?

Authors:  Marie Dagonnier; Geoffrey A Donnan; Stephen M Davis; Helen M Dewey; David W Howells
Journal:  Front Neurol       Date:  2021-02-05       Impact factor: 4.003

9.  Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature.

Authors:  Angelos Sharobeam; Brett Jones; Dianne Walton-Sonda; Christian J Lueck
Journal:  J Neurol       Date:  2020-03-21       Impact factor: 4.849

10.  Machine learning is a valid method for predicting prehospital delay after acute ischemic stroke.

Authors:  Li Yang; Qinqin Liu; Qiuli Zhao; Xuemei Zhu; Ling Wang
Journal:  Brain Behav       Date:  2020-08-18       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.